{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:45:09Z","timestamp":1776473109881,"version":"3.51.2"},"reference-count":87,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.2217\/pgs.13.54","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T11:19:23Z","timestamp":1368011963000},"page":"799-811","source":"Crossref","is-referenced-by-count":43,"title":["Evaluation of 5-Fluorouracil Pharmacokinetic Models and Therapeutic Drug Monitoring in Cancer Patients"],"prefix":"10.1080","volume":"14","author":[{"given":"Andr\u00e9 BP","family":"van Kuilenburg","sequence":"first","affiliation":[{"name":"Academic Medical Center, University of Amsterdam, Emma Children\u2018s Hospital & Department of Clinical Chemistry, Laboratory Genetic Metabolic Diseases, F0-220, Meibergdreef 9, 1105AZAmsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Gerard","family":"Maring","sequence":"additional","affiliation":[{"name":"Diaconessen Hospital Meppel & Bethesda Hospital Hoogeveen, Department of Pharmacy, Meppel, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,5,8]]},"reference":[{"key":"e_1_3_3_3_1_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200502000-00004"},{"key":"e_1_3_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2001.00174.x"},{"key":"e_1_3_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1286287"},{"key":"e_1_3_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2007.09.015"},{"key":"e_1_3_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2011.01529.x"},{"key":"e_1_3_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802193380803"},{"key":"e_1_3_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3182557342"},{"key":"e_1_3_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.4.1105"},{"key":"e_1_3_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2012.05.004"},{"key":"e_1_3_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0357"},{"key":"e_1_3_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.12.132"},{"key":"e_1_3_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040958"},{"key":"e_1_3_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043116"},{"key":"e_1_3_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.6771"},{"key":"e_1_3_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.5645"},{"key":"e_1_3_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e3283479c83"},{"key":"e_1_3_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2013.0022"},{"key":"e_1_3_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl284"},{"key":"e_1_3_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.6.1291"},{"key":"e_1_3_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.4.1470"},{"key":"e_1_3_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.7.1171"},{"key":"e_1_3_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(97)00345-6"},{"key":"e_1_3_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp328"},{"key":"e_1_3_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03257473"},{"key":"e_1_3_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1517\/14622416.3.4.485"},{"key":"e_1_3_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2003.12.004"},{"issue":"12","key":"e_1_3_3_3_27_1","first-page":"4705","article-title":"Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene.","volume":"6","author":"van Kuilenburg ABP","year":"2000","unstructured":"van Kuilenburg ABP , HaasjesJ, RichelDJ et al. Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene. Clin. Cancer Res. 6(12) , 4705\u20134712 (2000).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690098"},{"key":"e_1_3_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000245771.82720.c7"},{"key":"e_1_3_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012294617392"},{"key":"e_1_3_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-8428(98)00036-5"},{"key":"e_1_3_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600208"},{"key":"e_1_3_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.3934"},{"key":"e_1_3_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.109352"},{"key":"e_1_3_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1980.156"},{"key":"e_1_3_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00434346"},{"issue":"16","key":"e_1_3_3_3_37_1","first-page":"3415","article-title":"Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma.","volume":"57","author":"Kissel J","year":"1997","unstructured":"Kissel J , BrixG, BellemannME et al. Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma. Cancer Res. 57(16) , 3415\u20133423 (1997).","journal-title":"Cancer Res."},{"key":"e_1_3_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00194971"},{"key":"e_1_3_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1991.60"},{"key":"e_1_3_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.5.1581"},{"issue":"3","key":"e_1_3_3_3_41_1","first-page":"1499","article-title":"Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.","volume":"46","author":"Wagner JG","year":"1986","unstructured":"Wagner JG , GyvesJW, StetsonPL et al. Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients. Cancer Res. 46(3) , 1499\u20131506 (1986).","journal-title":"Cancer Res."},{"key":"e_1_3_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00257748"},{"key":"e_1_3_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-197803040-00006"},{"key":"e_1_3_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.2174\/156802612803531414"},{"key":"e_1_3_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.3109\/02841869609098503"},{"key":"e_1_3_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(98)00175-0"},{"issue":"6","key":"e_1_3_3_3_47_1","first-page":"1676","volume":"48","author":"Petit E","year":"1988","unstructured":"Petit E , MilanoG, LeviF, ThyssA, BailleulF, SchneiderM. Circadian rhythm-varying plasma concentration of 5-fluorouracil during a five-day continuous venous infusion at a constant rate in cancer patients. Cancer Res.48(6) , 1676\u20131679 (1988).","journal-title":"Cancer Res."},{"issue":"1","key":"e_1_3_3_3_48_1","first-page":"197","volume":"50","author":"Harris BE","year":"1990","unstructured":"Harris BE , SongR, SoongSJ, DiasioRB. Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. Cancer Res.50(1) , 197\u2013201 (1990).","journal-title":"Cancer Res."},{"key":"e_1_3_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.123"},{"key":"e_1_3_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3181b9b8c0"},{"key":"e_1_3_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1989.59"},{"issue":"9","key":"e_1_3_3_3_52_1","first-page":"2039","article-title":"Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas.","volume":"4","author":"Fety R","year":"1998","unstructured":"Fety R , RollandF, Barberi-HeyobM et al. Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas. Clin. Cancer Res. 4(9) , 2039\u20132045 (1998).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-003-0658-0"},{"issue":"8","key":"e_1_3_3_3_54_1","first-page":"3032","volume":"6","author":"Bocci G","year":"2000","unstructured":"Bocci G , DanesiR, Di Paolo AD et al. Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients. Clin. Cancer Res.6(8) , 3032\u20133037 (2000).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.06.007"},{"key":"e_1_3_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.128867"},{"issue":"8","key":"e_1_3_3_3_57_1","first-page":"2203","volume":"47","author":"Heggie GD","year":"1987","unstructured":"Heggie GD , SommadossiJP, CrossDS, HusterWJ, DiasioRB. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Res.47(8) , 2203\u20132206 (1987).","journal-title":"Cancer Res."},{"key":"e_1_3_3_3_58_1","first-page":"5405","volume":"45","author":"Naguib FN","year":"1985","unstructured":"Naguib FN , el Kouni MH. Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res.45(11 Pt 1) , 5405\u20135412 (1985).","journal-title":"Cancer Res."},{"key":"e_1_3_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690097"},{"key":"e_1_3_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80259-9"},{"key":"e_1_3_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113308"},{"key":"e_1_3_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2005.17.3.315"},{"key":"e_1_3_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1080\/15257770802145009"},{"key":"e_1_3_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10599"},{"key":"e_1_3_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200206000-00016"},{"key":"e_1_3_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2006.09.006"},{"key":"e_1_3_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0374"},{"key":"e_1_3_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/07357900500524702"},{"key":"e_1_3_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.3816\/CCC.2010.n.033"},{"key":"e_1_3_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-011-1661-5"},{"key":"e_1_3_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/PL00008711"},{"key":"e_1_3_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.11.72"},{"key":"e_1_3_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0327"},{"key":"e_1_3_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.10.4182"},{"key":"e_1_3_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2209"},{"key":"e_1_3_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200004000-00002"},{"key":"e_1_3_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-010-0879-3"},{"key":"e_1_3_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01765.x"},{"key":"e_1_3_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015716617967"},{"key":"e_1_3_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.759939"},{"key":"e_1_3_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-012-2007-7"},{"key":"e_1_3_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00689701"},{"key":"e_1_3_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199310000-00006"},{"key":"e_1_3_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002800050980"},{"key":"e_1_3_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.10374"},{"key":"e_1_3_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-002-0535-2"},{"key":"e_1_3_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270010396710"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs.13.54","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:48:29Z","timestamp":1715953709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs.13.54"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":87,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.2217\/pgs.13.54"],"URL":"https:\/\/doi.org\/10.2217\/pgs.13.54","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}